|
1
|
Cancer Genome Atlas Research Network, .
Comprehensive molecular characterization of urothelial bladder
carcinoma. Nature. 507:315–322. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Malats N and Real FX: Epidemiology of
bladder cancer. Hematol Oncol Clin North Am. 29:177–189, vii. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Burger M, Catto JW, Dalbagni G, Grossman
HB, Herr H, Karakiewicz P, Kassouf W, Kiemeney LA, La Vecchia C,
Shariat S and Lotan Y: Epidemiology and risk factors of urothelial
bladder cancer. Eur Urol. 63:234–241. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Käsmann L, Manig L, Janssen S and Rades D:
Chemoradiation including paclitaxel for locally recurrent
muscle-invasive bladder cancer in elderly patients. In Vivo.
31:239–241. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ide H, Inoue S and Miyamoto H:
Histopathological and prognostic significance of the expression of
sex hormone receptors in bladder cancer: A meta-analysis of
immunohistochemical studies. PLoS One. 12:e01747462017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wilczynska A and Bushell M: The complexity
of miRNA-mediated repression. Cell Death Differ. 22:22–33. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gottardo F, Liu CG, Ferracin M, Calin GA,
Fassan M, Bassi P, Sevignani C, Byrne D, Negrini M, Pagano F, et
al: Micro-RNA profiling in kidney and bladder cancers. Urol Oncol.
25:387–392. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen YH, Wang SQ, Wu XL, Shen M, Chen ZG,
Chen XG, Liu YX, Zhu XL, Guo F, Duan XZ, et al: Characterization of
microRNAs expression profiling in one group of Chinese urothelial
cell carcinoma identified by Solexa sequencing. Urol Oncol.
31:219–227. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xia H, Cheung WK, Ng SS, Jiang X, Jiang S,
Sze J, Leung GK, Lu G, Chan DT, Bian XW, et al: Loss of
brain-enriched miR-124 microRNA enhances stem-like traits and
invasiveness of glioma cells. J Biol Chem. 287:9962–9971. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shimizu T, Suzuki H, Nojima M, Kitamura H,
Yamamoto E, Maruyama R, Ashida M, Hatahira T, Kai M, Masumori N, et
al: Methylation of a panel of microRNA genes is a novel biomarker
for detection of bladder cancer. Eur Urol. 63:1091–1100. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hu CB, Li QL, Hu JF, Zhang Q, Xie JP and
Deng L: miR-124 inhibits growth and invasion of gastric cancer by
targeting ROCK1. Asian Pac J Cancer Prev. 15:6543–6546. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Feng T, Xu D, Tu C, Li W, Ning Y, Ding J,
Wang S, Yuan L, Xu N, Qian K, et al: MiR-124 inhibits cell
proliferation in breast cancer through downregulation of CDK4.
Tumour Biol. 36:5987–5997. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou L, Xu Z, Ren X, Chen K and Xin S:
MicroRNA-124 (MiR-124) inhibits cell proliferation, metastasis and
invasion in colorectal cancer by downregulating Rho-associated
protein kinase 1(ROCK1). Cell Physiol Biochem. 38:1785–1795. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li X, Yu Z, Li Y, Liu S, Gao C, Hou X, Yao
R and Cui L: The tumor suppressor miR-124 inhibits cell
proliferation by targeting STAT3 and functions as a prognostic
marker for postoperative NSCLC patients. Int J Oncol. 46:798–808.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Banaei-Esfahani A, Moazzeni H, Nosar PN,
Amin S, Arefian E, Soleimani M, Yazdani S and Elahi E: MicroRNAs
that target RGS5. Iran J Basic Med Sci. 18:108–114. 2015.PubMed/NCBI
|
|
18
|
Calin GA, Dumitru CD, Shimizu M, Bichi R,
Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, et al:
Frequent deletions and down-regulation of micro-RNA genes miR15 and
miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci
USA. 99:pp. 15524–15529. 2002; View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dong F, Xu T, Shen Y, Zhong S, Chen S,
Ding Q and Shen Z: Dysregulation of miRNAs in bladder cancer:
Altered expression with aberrant biogenesis procedure. Oncotarget.
8:27547–27568. 2017.PubMed/NCBI
|
|
20
|
Zhang T, Wang J, Zhai X, Li H, Li C and
Chang J: MiR-124 retards bladder cancer growth by directly
targeting CDK4. Acta Biochim Biophys Sin (Shanghai). 46:1072–1079.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang X, Wu Q, Xu B, Wang P, Fan W, Cai Y,
Gu X and Meng F: MiR-124 exerts tumor suppressive functions on the
cell proliferation, motility and angiogenesis of bladder cancer by
fine-tuning UHRF1. FEBS J. 282:4376–4388. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu X, Li S, Lin Y, Chen H, Hu Z, Mao Y, Xu
X, Wu J, Zhu Y, Zheng X, et al: MicroRNA-124-3p inhibits cell
migration and invasion in bladder cancer cells by targeting ROCK1.
J Transl Med. 11:2762013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cheng Y, Li Y, Nian Y, Liu D, Dai F and
Zhang J: STAT3 is involved in miR-124-mediated suppressive effects
on esophageal cancer cells. BMC Cancer. 15:3062015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wan J, Zhao XF, Vojtek A and Goldman D:
Retinal injury, growth factors, and cytokines converge on β-catenin
and pStat3 signaling to stimulate retina regeneration. Cell Rep.
9:285–297. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
De Simone V, Franzè E, Ronchetti G,
Colantoni A, Fantini MC, Di Fusco D, Sica GS, Sileri P, MacDonald
TT, Pallone F, et al: Th17-type cytokines, IL-6 and TNF-α
synergistically activate STAT3 and NF-kB to promote colorectal
cancer cell growth. Oncogene. 34:3493–3503. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
O'Reilly S, Ciechomska M, Cant R and van
Laar JM: Interleukin-6 (IL-6) trans signaling drives a
STAT3-dependent pathway that leads to hyperactive transforming
growth factor-β (TGF-β) signaling promoting SMAD3 activation and
fibrosis via Gremlin protein. J Biol Chem. 289:9952–9960. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Siveen KS, Sikka S, Surana R, Dai X, Zhang
J, Kumar AP, Tan BK, Sethi G and Bishayee A: Targeting the STAT3
signaling pathway in cancer: Role of synthetic and natural
inhibitors. Biochim Biophys Acta. 1845:136–154. 2014.PubMed/NCBI
|
|
28
|
Huang SY, Chang SF, Liao KF and Chiu SC:
Tanshinone IIA inhibits epithelial-mesenchymal transition in
bladder cancer cells via modulation of STAT3-CCL2 signaling. Int J
Mol Sci. 18(pii): E16162017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang J, Ren Y, Lou ZG, Wan X, Weng GB and
Cen D: Paeoniflorin inhibits the growth of bladder carcinoma via
deactivation of STAT3. Acta Pharm. 68:211–222. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ho PL, Lay EJ, Jian W, Parra D and Chan
KS: Stat3 activation in urothelial stem cells leads to direct
progression to invasive bladder cancer. Cancer Res. 72:3135–3142.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang T, Kee WH, Seow KT, Fung W and Cao
X: The coiled-coil domain of Stat3 is essential for its SH2
domain-mediated receptor binding and subsequent activation induced
by epidermal growth factor and interleukin-6. Mol Cell Biol.
20:7132–7139. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huang TT, Su JC, Liu CY, Shiau CW and Chen
KF: Alteration of SHP-1/p-STAT3 signaling: A potential target for
anticancer therapy. Int J Mol Sci. 18:2017. View Article : Google Scholar
|
|
33
|
Kamran MZ, Patil P and Gude RP: Role of
STAT3 in cancer metastasis and translational advances. Biomed Res
Int. 2013:4218212013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Carpenter RL and Lo HW: STAT3 target genes
relevant to human cancers. Cancers (Basel). 6:897–925. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bowman T, Garcia R, Turkson J and Jove R:
STATs in oncogenesis. Oncogene. 19:2474–2488. 2000. View Article : Google Scholar : PubMed/NCBI
|
